$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000141169023000071 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$9.318M	$8.662M
YoY Change	29.04%	29.87%
Cost Of Revenue	$6.569M	$6.354M
YoY Change	21.38%	22.22%
Gross Profit	$2.749M	$2.308M
YoY Change	51.96%	56.9%
Gross Profit Margin	29.5%	26.65%
Selling, General & Admin	$24.90M	$26.94M
YoY Change	17.35%	23.66%
% of Gross Profit	905.64%	1167.07%
Research & Development	$13.79M	$14.61M
YoY Change	8.19%	24.16%
% of Gross Profit	501.46%	633.02%
Depreciation & Amortization	$3.680M	$3.348M
YoY Change	51.38%	42.29%
% of Gross Profit	133.87%	145.06%
Operating Expenses	$38.68M	$41.55M
YoY Change	13.91%	23.83%
Operating Profit	-$113.2M	-$39.24M
YoY Change	252.15%	22.32%
Interest Expense	$71.00K	$74.00K
YoY Change	-2.74%	0.0%
% of Operating Profit
Other Income/Expense, Net	$685.0K	$359.0K
YoY Change	86.14%	-1044.74%
Pretax Income	-$112.5M	-$38.88M
YoY Change	254.07%	21.05%
Income Tax	$39.00K	$33.00K
% Of Pretax Income
Net Earnings	-$112.6M	-$38.91M
YoY Change	253.88%	21.0%
Net Earnings / Revenue	-1208.05%	-449.23%
Basic Earnings Per Share	-$3.22	-$1.24
Diluted Earnings Per Share	-$3.22	-$1.24
COMMON SHARES
Basic Shares Outstanding	35.35M shares	306.8M shares
Diluted Shares Outstanding	35.00M shares	31.50M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.60M	$77.10M
YoY Change	-64.71%	-58.86%
Cash & Equivalents	$34.60M	$14.90M
Short-Term Investments	$29.00M	$62.20M
Other Short-Term Assets	$5.900M	$5.447M
YoY Change	-17.27%	55.23%
Inventory	$33.51M	$32.45M
Prepaid Expenses
Receivables	$8.669M	$7.613M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$104.5M	$122.6M
YoY Change	-52.09%	-43.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.27M	$20.26M
YoY Change	34.09%	45.54%
Goodwill	$0.00	$77.28M
YoY Change	-100.0%	37.38%
Intangibles	$35.77M	$37.56M
YoY Change	58.36%	56.46%
Long-Term Investments
YoY Change
Other Assets	$10.21M	$3.000M
YoY Change	1173.07%	256.72%
Total Long-Term Assets	$77.37M	$148.8M
YoY Change	-26.67%	41.36%
TOTAL ASSETS
Total Short-Term Assets	$104.5M	$122.6M
Total Long-Term Assets	$77.37M	$148.8M
Total Assets	$181.9M	$271.4M
YoY Change	-43.8%	-15.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.37M	$11.91M
YoY Change	63.38%	54.8%
Accrued Expenses	$11.55M	$8.316M
YoY Change	-1.62%	7.16%
Deferred Revenue	$811.0K	$978.0K
YoY Change	-16.91%	-17.12%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$279.0K
YoY Change	4.17%	-4.45%
Total Short-Term Liabilities	$40.19M	$33.50M
YoY Change	19.98%	20.03%
LONG-TERM LIABILITIES
Long-Term Debt	$3.600M	$3.604M
YoY Change	-0.72%	-0.77%
Other Long-Term Liabilities	$19.10M	$19.52M
YoY Change	295.45%	269.87%
Total Long-Term Liabilities	$22.70M	$23.13M
YoY Change	168.45%	159.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$40.19M	$33.50M
Total Long-Term Liabilities	$22.70M	$23.13M
Total Liabilities	$62.91M	$56.63M
YoY Change	49.93%	53.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$537.3M	-$424.8M
YoY Change	73.3%	52.68%
Common Stock	$656.4M	$639.8M
YoY Change	10.58%	13.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$119.0M	$214.8M
YoY Change
Total Liabilities & Shareholders Equity	$181.9M	$271.4M
YoY Change	-43.8%	-15.6%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$112.6M	-$38.91M
YoY Change	253.88%	21.0%
Depreciation, Depletion And Amortization	$3.680M	$3.348M
YoY Change	51.38%	42.29%
Cash From Operating Activities	-$26.29M	-$36.70M
YoY Change	-10.8%	29.52%
INVESTING ACTIVITIES
Capital Expenditures	$80.00K	$511.0K
YoY Change	-127.59%	-208.96%
Acquisitions
YoY Change
Other Investing Activities	$33.50M	$30.09M
YoY Change	306.41%	-5.12%
Cash From Investing Activities	$33.43M	$29.58M
YoY Change	320.34%	-5.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.59M	17.88M
YoY Change	-44.42%	8708.37%
NET CHANGE
Cash From Operating Activities	-26.29M	-36.70M
Cash From Investing Activities	33.43M	29.58M
Cash From Financing Activities	12.59M	17.88M
Net Change In Cash	19.73M	10.76M
YoY Change	1644.47%	245.9%
FREE CASH FLOW
Cash From Operating Activities	-$26.29M	-$36.70M
Capital Expenditures	$80.00K	$511.0K
Free Cash Flow	-$26.37M	-$37.21M
YoY Change	-9.64%	33.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P6M
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	bngo	Stockholders Equity Reverse Stock Split Percentage Of Outstanding Common Stock Are Present StockholdersEquityReverseStockSplitPercentageOfOutstandingCommonStockArePresent	0.33
CY2023Q2	us-gaap	Inventory Net InventoryNet	32453000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	29761000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62024000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	689000	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	192000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1392000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	74000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	41546000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	33550000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	81460000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	64356000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-39238000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-32079000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-77083000	usd
	us-gaap	Interest Expense InterestExpense	151000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5102000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-29952000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1098000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	311185000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	136000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5777000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	75000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-38879000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.24
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31498000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31498000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28555000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28555000	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	365000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-281000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	787000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1379000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-10000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	355000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38557000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	337118000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32158000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-281000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	284734000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3882000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14848000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-37124000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	231486000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17802000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	92000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	355000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	214756000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-76038000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62112000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6487000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4475000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	102000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	117000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	226000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-551000	usd
	bngo	Non Cash Lease Expense NonCashLeaseExpense	20000	usd
	bngo	Non Cash Lease Expense NonCashLeaseExpense	337000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-23000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7814000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	10879000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2218000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	158000	usd
	bngo	Cost Of Leased Equipment Sold To Customer CostOfLeasedEquipmentSoldToCustomer	88000	usd
	bngo	Cost Of Leased Equipment Sold To Customer CostOfLeasedEquipmentSoldToCustomer	204000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	590000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7345000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12095000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1785000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-277000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	587000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	91000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-791000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2073000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2069000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1477000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69109000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60826000	usd
	bngo	Proceeds From Business Combination Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationReturnOfPurchaseConsiderationFromEscrow	96000	usd
	bngo	Proceeds From Business Combination Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationReturnOfPurchaseConsiderationFromEscrow	694000	usd
	bngo	Payments For Property And Equipment PaymentsForPropertyAndEquipment	839000	usd
	bngo	Payments For Property And Equipment PaymentsForPropertyAndEquipment	371000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	29541000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	46879000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	93475000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	32000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1080000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	27000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46104000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	63204000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	22000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	33487000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	837000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	92000	usd
	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	75000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	23000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	152000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32743000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	210000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9765000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2588000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5491000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24571000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	15256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	27159000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14856000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27159000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	400000	usd
CY2022Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27159000	usd
	us-gaap	Interest Paid Net InterestPaidNet	149000	usd
	us-gaap	Interest Paid Net InterestPaidNet	139000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1291000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	695000	usd
	bngo	Transfer Of Instruments And Servers To Property And Equipment From Inventory TransferOfInstrumentsAndServersToPropertyAndEquipmentFromInventory	4615000	usd
	bngo	Transfer Of Instruments And Servers To Property And Equipment From Inventory TransferOfInstrumentsAndServersToPropertyAndEquipmentFromInventory	3890000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	104000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	65000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	517000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts reported in prior years have been reclassified to conform with the presentation in the current year. These reclassifications had no effect on the reported results of operations.</span></div>
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	62200000	usd
CY2023Q2	bngo	Working Capital WorkingCapital	89100000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-424800000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69100000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4041000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3231000	shares
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8662000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6670000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16077000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12366000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8662000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6670000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16077000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12366000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1200000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.617
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.312
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.071
CY2023Q2	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	400000	usd
CY2022Q2	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	200000	usd
	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	1100000	usd
	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	500000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7875000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7315000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	262000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	293000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7613000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7022000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	293000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-5000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	36000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	262000	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	6204000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	5319000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10577000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7055000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15672000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17387000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	32453000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	29761000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48380000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10923000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	37457000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48380000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7339000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	41041000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5917000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7002000	usd
CY2023Q2	us-gaap	Deposit Liability Current DepositLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	17000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	897000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	825000	usd
CY2023Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	125000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	613000	usd
CY2023Q2	bngo	Professional Fees And Royalties Current ProfessionalFeesAndRoyaltiesCurrent	153000	usd
CY2022Q4	bngo	Professional Fees And Royalties Current ProfessionalFeesAndRoyaltiesCurrent	210000	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	640000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	489000	usd
CY2023Q2	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	150000	usd
CY2022Q4	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	250000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	417000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1146000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8316000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10552000	usd
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	700000	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	34.59
CY2022Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	23100000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	600000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3500000	shares
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	9.56
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	33500000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	800000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	436000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	59.60
CY2022	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P0Y9M3D
CY2022Q4	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	273000	usd
	bngo	Class Of Warrant Or Right Number Of Securities Granted In Period ClassOfWarrantOrRightNumberOfSecuritiesGrantedInPeriod	0	shares
	bngo	Class Of Warrant Or Right Number Of Securities Exercised In Period ClassOfWarrantOrRightNumberOfSecuritiesExercisedInPeriod	0	shares
	bngo	Class Of Warrant Or Right Number Of Securities Canceled In Period ClassOfWarrantOrRightNumberOfSecuritiesCanceledInPeriod	0	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	436000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	59.60
	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P0Y3M7D
CY2023Q2	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2402000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2068000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1181000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.10
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	25000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	233000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.20
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3346000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M17D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	148000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1108000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	33.90
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y8M4D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	131000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.47
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3932000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5777000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7814000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10879000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.039
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.805
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.706
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.744
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.702
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1295000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	162000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2684000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	330000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2788000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	338000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	729000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	347000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	255000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	356000	usd
CY2023Q2	bngo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2023Q2	bngo	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	5594000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7751000	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7127000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	971000	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3244000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6780000	usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	3883000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedLossMaturityAllocatedAndSingleMaturityDateYearOne	1000000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	93915000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	109182000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	15	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	16	security
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	11	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	24	security
CY2023Q2	us-gaap	Interest Receivable InterestReceivable	400000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	500000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	62505000	usd
CY2023Q2	bngo	Debt Securities Available For Sale Unrealized Gain Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedGainMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2023Q2	bngo	Debt Securities Available For Sale Unrealized Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedLossMaturityAllocatedAndSingleMaturityDateYearOne	299000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	62206000	usd
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	62505000	usd
CY2023Q2	bngo	Debt Securities Available For Sale Unrealized Gains DebtSecuritiesAvailableForSaleUnrealizedGains	0	usd
CY2023Q2	bngo	Debt Securities Available For Sale Unrealized Loss DebtSecuritiesAvailableForSaleUnrealizedLoss	299000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	62206000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	94914000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Gain Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedGainMaturityAllocatedAndSingleMaturityDateYearOne	1000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Gains DebtSecuritiesAvailableForSaleUnrealizedGains	1000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Loss DebtSecuritiesAvailableForSaleUnrealizedLoss	1088000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	108095000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	25631000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	67000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	36575000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	232000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	62206000	usd
CY2023Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	299000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	31662000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	116000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	74452000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	972000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	106114000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1088000	usd

Files In Submission

Name	View Source	Status
0001411690-23-000071-index-headers.html	Edgar Link	pending
0001411690-23-000071-index.html	Edgar Link	pending
0001411690-23-000071.txt	Edgar Link	pending
0001411690-23-000071-xbrl.zip	Edgar Link	pending
bngo-20230630.htm	Edgar Link	pending
bngo-20230630.xsd	Edgar Link	pending
bngo-20230630xexx311.htm	Edgar Link	pending
bngo-20230630xexx312.htm	Edgar Link	pending
bngo-20230630xexx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
bngo-20230630_cal.xml	Edgar Link	unprocessable
bngo-20230630_lab.xml	Edgar Link	unprocessable
bngo-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bngo-20230630_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bngo-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2023 Q3 Form 10-Q Financial Statement

#000141169023000071 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2023 Q3 Form 10-Q Financial Statement

#000141169023000071 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo